EDN1 and in situ carcinoma: Macitentan inhibited the ET-1-induced expression of ZEB1 in OVCAR-3, A2780 cells, and even in A2780 CIS cells that, as expected, showed higher levels of ZEB1 (Supplementary Fig. 6b).